Inventurus Knowledge Solutions Limited (IN:IKS)
:IKS
Top Page
Inventurus Knowledge Solutions Limited
(IKS)
Select Model
Select Model
Rating:75Outperform
Price Target:
₹1,541.00
▼(-7.91% Downside)
Action:UpgradedDate:10/29/25
Inventurus Knowledge Solutions exhibits strong financial performance with robust revenue growth and profitability, contributing significantly to the overall score. Technical analysis indicates stable momentum, supporting a positive outlook. However, the absence of valuation metrics introduces some uncertainty, slightly tempering the overall score.
Positive Factors
High revenue growth
A three-year revenue CAGR above 40% signals strong demand and scalable delivery for its healthcare RCM services. Sustained double-digit growth supports reinvestment in technology and capacity, enabling the company to broaden client engagements and lock in recurring B2B service revenue over the medium term.
Negative Factors
Volatile net debt levels
Periodic swings in net debt suggest timing or structural variability in cash management that can constrain flexibility. Even with improving leverage, volatile net debt raises refinancing and liquidity risk during stress periods and may force suboptimal financing or delayed investments.
Read all positive and negative factors
Positive Factors
Negative Factors
High revenue growth
A three-year revenue CAGR above 40% signals strong demand and scalable delivery for its healthcare RCM services. Sustained double-digit growth supports reinvestment in technology and capacity, enabling the company to broaden client engagements and lock in recurring B2B service revenue over the medium term.
Read all positive factors
Inventurus Knowledge Solutions Limited (IKS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹236.34B
Dividend YieldN/A
Average Volume (3M)4.58K
Price to Earnings (P/E)37.8
Beta (1Y)0.46
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees7,530
SectorServices
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)10.70
Shares Outstanding171,573,170
10 Day Avg. Volume2,488
30 Day Avg. Volume4,579
Financial Highlights & Ratios
PEG Ratio1.45
Price to Book (P/B)13.85
Price to Sales (P/S)9.31
P/FCF Ratio84.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,500.00Price Target Upside-10.36% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)52.44
Revenue Forecast (FY)₹38.05B
Inventurus Knowledge Solutions Limited Business Overview & Revenue Model
Company Description
Inventurus Knowledge Solutions Ltd. engages in the provision of coding and scribe services, and delivering medical transcriptions. It operates through its sole segment of Healthcare. The Healthcare segment represents providing focused cost and pro...
How the Company Makes Money
IKS makes money primarily by providing outsourced, healthcare-specific operational services—most notably revenue cycle management (RCM)—to healthcare organizations under contracted service arrangements. Revenue is earned through service fees for e...
Inventurus Knowledge Solutions Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.63B | 26.64B | 18.17B | 10.31B | 7.64B | 5.53B |
| Gross Profit | 8.37B | 26.63B | 18.16B | 5.05B | 3.59B | 2.47B |
| EBITDA | 8.47B | 8.09B | 5.61B | 3.89B | 2.98B | 1.82B |
| Net Income | 5.33B | 4.86B | 3.70B | 3.05B | 2.33B | 1.65B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 30.52B | 30.28B | 9.88B | 7.88B | 5.86B |
| Cash, Cash Equivalents and Short-Term Investments | 1.92B | 2.19B | 4.83B | 5.23B | 3.47B | 2.24B |
| Total Debt | 0.00 | 8.56B | 13.11B | 523.46M | 651.92M | 760.29M |
| Total Liabilities | -17.90B | 12.62B | 18.70B | 1.60B | 1.40B | 1.29B |
| Stockholders Equity | 17.90B | 17.90B | 11.58B | 8.29B | 6.47B | 4.57B |
Cash Flow | ||||||
| Free Cash Flow | 1.06B | 2.93B | 1.77B | 2.79B | 2.22B | 1.68B |
| Operating Cash Flow | 1.19B | 3.18B | 2.10B | 2.88B | 2.33B | 1.75B |
| Investing Cash Flow | 1.42B | 2.44B | -11.41B | -1.56B | -824.48M | -1.66B |
| Financing Cash Flow | -1.37B | -3.89B | 7.80B | -1.52B | -585.10M | -365.65M |
Inventurus Knowledge Solutions Limited Technical Analysis
Neutral
1673.35
Price Trends
1491.17
Negative
1575.96
Negative
1575.71
Negative
Market Momentum
-38.92
Negative
47.33
Neutral
77.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:IKS, the sentiment is Neutral. The current price of 1673.35 is above the 20-day moving average (MA) of 1338.08, above the 50-day MA of 1491.17, and above the 200-day MA of 1575.71, indicating a neutral trend. The MACD of -38.92 indicates Negative momentum. The RSI at 47.33 is Neutral, neither overbought nor oversold. The STOCH value of 77.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:IKS.
Inventurus Knowledge Solutions Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹236.34B | 37.81 | ― | ― | ― | ― | |
69 Neutral | ₹140.52B | 28.61 | ― | 0.02% | 17.83% | 20.34% | |
64 Neutral | ₹84.53B | 60.39 | ― | ― | 22.95% | 284.54% | |
62 Neutral | ₹158.57B | 48.02 | ― | 1.13% | 25.92% | 24.58% | |
60 Neutral | ₹51.20B | 55.57 | ― | 0.40% | 11.56% | -2.78% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
55 Neutral | ₹17.32B | 12.17 | ― | 1.51% | -2.43% | -100.43% |
* Services Sector Average
IN:IKS
Inventurus Knowledge Solutions Limited
1,410.90
53.45
3.94%
IN:CARTRADE
CarTrade Tech Ltd.
1,765.50
241.05
15.81%
IN:ECLERX
eClerx Services Limited
1,494.10
241.74
19.30%
IN:FSL
Firstsource Solutions Limited
227.50
-85.37
-27.29%
IN:HGS
Hinduja Global Solutions Limited
372.40
-96.50
-20.58%
IN:IONEXCHANG
Ion Exchange (India) Ltd.
349.10
-116.69
-25.05%
Inventurus Knowledge Solutions Limited Corporate Events
Inventurus Knowledge Solutions Injects USD 19 Million into U.S. Subsidiary
Mar 27, 2026
Inventurus Knowledge Solutions Limited has increased its stake in its wholly owned subsidiary, Inventurus Knowledge Solutions, Inc., by acquiring 29,541 shares in a first investment tranche valued at USD 19,000,476. This follow-on capital deployme...
Inventurus Knowledge Solutions to Invest Up to USD 40 Million in Healthcare Tech Subsidiary
Mar 13, 2026
Inventurus Knowledge Solutions Limited has approved a further investment of up to USD 40 million in its wholly owned U.S. subsidiary Inventurus Knowledge Solutions Inc., which operates a care enablement platform for healthcare providers. The trans...
Inventurus Knowledge Solutions Grants 600,000 Stock Options Under 2022 ESOP
Mar 5, 2026
Inventurus Knowledge Solutions Limited has granted 600,000 employee stock options under its 2022 Employee Stock Option Plan, following approval by the Nomination and Remuneration Committee on March 5, 2026. Each option is convertible into one equi...
IKS Health Posts Double-Digit Q3 Growth on U.S. Platform Demand
Feb 4, 2026
The company posted Q3 FY26 revenue of INR 8,150 million, up 24% year on year, with EBITDA rising 40% and PAT climbing 41%, reflecting sustained expansion across existing and newly won provider clients. Management highlighted that tightened U.S. ph...
Inventurus Knowledge Solutions Publishes Q3 FY26 Investor Presentation
Feb 4, 2026
Inventurus Knowledge Solutions Limited has released an investor presentation detailing its financial results for the quarter and nine months ended December 31, 2025, and has made the materials available to shareholders via its website. The disclos...
Inventurus Knowledge Solutions Cancels January 20 Analyst and Investor Meet
Jan 9, 2026
Inventurus Knowledge Solutions Limited has notified the stock exchanges that its planned analyst and institutional investor meeting, previously scheduled for 20 January 2026, will not take place. The company cited unforeseen scheduling exigencies ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.